Additional possibilities of chimeric antigen receptor T-cells in B-cell lymphoma: combination therapy

B-cell non-Hodgkin’s lymphoma (B-NHL) is a lymphoproliferative disorder that affects B lymphocytes. Chimeric antigen receptor (CAR) T-cell immunotherapy is a new type of immunotherapy that uses genetic engineering techniques to modify and expand the patient’s autoimmune cells in vitro, after which t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Zhou, Jing, Cao, Cong, Cai, Panpan, Wang, Xinxuan, Chang, Chun, Wang, Jingxuan, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798430/
https://www.ncbi.nlm.nih.gov/pubmed/35117332
http://dx.doi.org/10.21037/tcr-20-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798430/
https://www.ncbi.nlm.nih.gov/pubmed/35117332
http://dx.doi.org/10.21037/tcr-20-72

Ejemplares similares